International life sciences regulations: How CROs, CMOs, and CDMOs are primed for advantage
Vishal Goel, MD, Rx Propellant elaborates how Indian CROs, CMOs, and CDMOs can enhance their competitive edge by investing in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CDMOs
Passing of Biosecure Act a positive development
Jonathan Hunt MD and CEO, Syngene International analyses that though the change in the Biosecure Act around the timeline of…
India currently contributes three-to-five per cent share of the global biotechnology sector
The outsourcing market size for CDMOs in India is roughly at Rs 20,000 crores and it is expected to grow to about Rs 40,000 crores…